Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21

Trial Status

Other1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT05535218Phase 2Active Not Recruiting
Pembrolizumab-Sacituzumab Govitecan Combination to Treat High-risk, Localized Bladder Cancer
Muscle-invasive Urothelial Carcinoma of the Bladder
PrincipalinvestigatorStart date: 2023-09-20

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Won Sik Ham

Department of Urology and Urological Science Institute, Yonsei University College of Medicine Seoul, Republic of Korea

Related
1 trials

Shared therapeutic areas:

Muscle-invasive Bladder Cancer
Similarity Score15%

Julian Schardt, MD

Departement of Medical Oncology, University Hospital Berne

Related
1 trials

Shared therapeutic areas:

Muscle-invasive Bladder Cancer
Similarity Score15%

xiongjun YE

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Related
2 trials

Shared therapeutic areas:

Muscle-invasive Bladder Cancer
Similarity Score15%

Srikala Sridhar, MD

Princess Margaret Hospital, Canada

Related
1 trials

Shared therapeutic areas:

Muscle-invasive Bladder Cancer
Similarity Score15%

Andrea Necchi, MD

Fondazione IRCCS Istituto Nazionale Tumori-Milano

Related
1 trials

Shared therapeutic areas:

Muscle-invasive Bladder Cancer
Similarity Score15%

Zhuowei Liu, M.D Ph.D

Sun Yat-Sen University Cancer Center

Related
1 trials

Shared therapeutic areas:

Muscle-invasive Bladder Cancer
Similarity Score15%

Ur Metser, MD

Princess Margaret Hospital, Canada

Related
2 trials

Shared therapeutic areas:

Muscle-invasive Bladder Cancer
Similarity Score15%

Jianzhong Shou

National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College

Related
1 trials

Shared therapeutic areas:

Muscle-invasive Bladder Cancer
Similarity Score15%

Zejing Wang, MD/PhD

Pfizer

Related
1 trials

Shared therapeutic areas:

Muscle-invasive Bladder Cancer
Similarity Score15%

Nicholas Power, MD

LHSC-Victoria Hospital

Related
1 trials

Shared therapeutic areas:

Muscle-invasive Bladder Cancer
Similarity Score15%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT05535218Phase 2PrincipalInvestigator

Pembrolizumab-Sacituzumab Govitecan Combination to Treat High-risk, Localized Bladder Cancer

Muscle-invasive Urothelial Carcinoma of the Bladder
Active Not Recruiting

All 1 trials loaded